Pierre-Olivier Ferko

Pierre-Olivier Ferko

Smart & Biggar

Contact
View Bio
RSS

Latest Posts › Drug Pricing

Share:

Updated PMPRB Guidelines expected in summer 2025 and NPDUIS releases ninth edition of the Meds Entry Watch Report

In the Patented Medicine Prices Review Board (PMPRB)’s June 2025 NEWSletter, Acting Chairperson Anie Perrault confirms that the PMPRB plans on publishing its final Guidelines in summer 2025. This will mark the completion of...more

7/1/2025  /  Canada , Drug Pricing , Government Agencies , New Guidance , New Regulations , Pharmaceutical Industry , Pharmaceutical Patents , Prescription Drugs , Regulatory Agencies , Regulatory Reform

PMPRB announces Anie Perrault as acting Chairperson and releases latest expenditure report on private drug plan costs and...

On March 6, 2025, the Patented Medicine Prices Review Board (PMPRB) announced that Thomas Digby stepped down from his role as Chairperson of the PMPRB. Vice-Chairperson Anie Perrault is now serving as acting Chairperson until...more

3/25/2025  /  Canada , Corporate Governance , Drug Pricing , Healthcare , Healthcare Reform , Patented Medicine Prices Review Board (PMPRB) , Pharmaceutical Industry , Prescription Drugs , Regulatory Requirements , Reporting Requirements
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide